1.1. HLA and other leucocyte and platelet alloantigens in paternity testing (introductory lecture)

The analysis of lipstick stains presented here is a combination of several techniques. In addition to colour comparison and thin-layer chromatographic (TLC) analysis, X-ray analysis in a scanning electron microscope and high-performance liquid-chromatographic (HPLC) analysis have been used. X-ray analysis may be performed directly on the material bearing the stain. For TLC and HPLC analyses a solvent extract of the stain was used.Guidance is given for practical examination of lipstick stains. When using all the methods described in this paper, all the 117 different lipstick samples examined in this study could be distinguished from each other.     

The influence of cleaning agents to the result of abo blood-group determination by the agglutinin-binding test (holzer) at blood stain on articles of clothing (author's transl)]

The blood-group determination in the ABO-system during blood stain testing on articles of clothing is very often affected by various factors. In this research project blood-traces were tested on many different textiles and after treatment of these textiles with some usual washing and cleaning agents by the Agglutinin-binding-test (HOLZER).     

Validation studies of rapid stain identification-blood (RSID-blood) kit in forensic caseworks

When bloodstains are detected at crime scene using presumptive tests (e.g. luminol, phenolphthalein, leuchomalachite green), it is important to establish the real human nature of each stain. This is possible using confirmatory tests. One of these is rapid stain identification-blood (RISD-blood) a lateral flow immuno-chromatographic strip test format which allows the identification of human blood by detection of glycophorin A, a red blood cell membrane antigen, using two anti-human glycophorin A (GPA) monoclonal antibodies.The aim of this study is to assess the sensitivity of RSID-blood test in old, degraded bloodstains and in some bloodstains previously treated with BlueStar Forensic, a presumptive test which is often used in crime scene investigations to detect latent bloodstains. The genetic analysis of all bloodstains of confirmed human nature was subsequently performed using the AmpF1STR Identifiler PCR Amplification Kit (Applied Biosystems), to validate the possibility of obtain a consistent and reliable DNA typing results.     

An examination of a contaminated seminal stain using absorption-elution and enzyme-linked immunosorbent assay (ELISA)

A semen stain, apparently contaminated with a detergent cleanser, was received for examination. The contamination interfered with the normal biochemical reactions of such stains. Treatment of the sample enabled ABO groups to be determined.     

Liability of manufacturers and providers of health related goods and services: confronting the dilemma.

In this Article, Theodore Cooper, M.D., Assistant Secretary for Health at HEW, contends that the crush of lawsuits brought by aggrieved health care consumers against medical professionals and institutions, and drug and medical equipment manufacturers, may be the result, in large part, of a widely held impression--often encouraged by members of the health professions and industries themselves--that medicine has unlimited powers to heal. Dr. Cooper suggests that those involved in providing health care services and products--and members of the legal profession-have a responsibility to inform the public that this expectation is unrealistic and that everyone suffers when the number of such lawsuits and the size of damage awards are excessive.     

The blood group antigen Doa (Dombrock) in a German population sample

Blood samples from 300 unrelated persons in Northrhine-Westphalia (F.R.G.) have been tested for the Do^a (Dombrock) blood group antigen. 199 blood samples (66.3%) were found to be Do(a+).     

The typing of group-specific component (Gc protein) in human blood stains

It is known that the typing of group-specific component (Gc protein) in human blood stains is difficult since Gc protein of the extracts of blood stains migrates more anodally to the α₁-globulin region in agar-gel immunoelectrophoresis, while Gc protein in liquid blood normally migrates to the α₂-globulin region. We have reported that the Gc protein found in the α₁-region is the result of binding of actin to Gc protein (Shinomiya, K., Kimura, H., Yoshida, K., and Shinomiya, T., J. Biochem., 92 (1982) 1163–1171, which renders it difficult to determine the Gc-phenotypes in the blood stains. On the basis of the above findings, we developed the method of phenotyping the Gc protein of human blood stains by agar-gel immunoelectrophoresis. Since the binding activity of actin to Gc protein is lost after treatment with a high concentration of guanidine HCl, the extracts of blood stains were treated with 4 M guanidine HCl to dissociate Gc protein and actin and then dialyzed to remove guanidine HCl. By this method we are able to determine the phenotypes of Gc protein in blood stains. The method we have developed is a useful tool in the forensic laboratory.     

驾驶员酒后血液酒精含量与时间关系研究

目的研究驾驶员少量饮酒后体内酒精含量与时间的变化关系。方法利用呼吸式测酒器对驾驶员酒后30min以后血液酒精含量进行测量,每隔20-30min测量一次,绘出血液酒精含量与时间的关系曲线。结果血液酒精含量与时间的变化关系基本为线性关系,拟合曲线斜率略有差异。结论对于喝1瓶啤酒的情况,酒后30-60min内都降到20mg/100ml以下,可为驾驶员掌握酒后开车时间和交警执法检查提供数据参考。     

APM染色法在羊水栓塞诊断中的应用价值

目的　探讨APM染色法在羊水栓塞 (AFE)病理学诊断中的应用价值。方法　采用APM染色法对 1988年至 2 0 0 1年确诊为AFE的 19例病例 (AFE组 )和羊水吸入性肺炎的胎儿 3例 (阳性对照组 )、其它死因的 10例产妇 (阴性对照组 )重新进行染色和组织学检查 ,对其检验结果进行比较分析。结果　阳性组全部检出羊水成分 ,阴性组部分病例检出羊水成分 ,发现漏诊、误诊各 1例。与HE染色相比较 ,APM染色能提高角化上皮和粘液的检出率。结论　APM染色能提高羊水成分的检出率 ,有助于提高AFE诊断的准确性 ,可用于AFE病理学诊断。     

Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH plasma or serum to whole blood concentrations distribution ratios in blood samples taken from living and dead people.

The recreational use and abuse of Cannabis is continuously increasing in Switzerland. Cannabinoids are very often detected alone or in combination with other drugs in biological samples taken from drivers suspected of driving under the influence of drugs. Moreover, they are also frequently found in blood specimens from people involved in various medico-legal events, e.g. muggings, murders, rapes and working accidents as well. In order to assess the influence of Cannabis exposure on man behavior and performances, it is often needed to estimate the time of Cannabis use. For that purpose two mathematical models have been set up by Huestis and coworkers. These models are based on cannabinoids concentrations in plasma. Because plasma samples are rarely available for forensic determinations in our laboratory, it could be useful to assess the time-laps since Cannabis use through these models from whole blood values. One prerequisite to the use of these models from whole blood values is the knowledge of the plasma to whole blood concentrations distribution ratios of cannabinoids. In this respect, the Delta(9)-THC, 11-OH-Delta(9)-THC and Delta(9)-THCCOOH concentrations were measured in plasma and whole blood taken from eight volunteers who smoke Cannabis on a regular basis. Cannabinoids levels were also determined in "serum" and whole blood samples taken from six corpses. The values of the plasma to whole blood distribution ratios were found to be very similar and their individual coefficient of variation relatively low suggesting that plasma levels could be calculated from whole blood concentrations taken into account a multiplying factor of 1.6. The data obtained postmortem suggest that the distribution of cannabinoids between whole blood and "serum" is scattered over a larger range of values than those determined from living people and that more cannabinoids (mean value of the serum/whole blood concentrations ratios=2.4) can be recovered from the "serum" fraction. The successful use of the mathematical models of Huestis and coworkers may, therefore, rely in part upon the selection of the appropriate blood sample, i.e. plasma. When plasma is not available, whole blood values could be considered with some caution taken into account a multiplying factor of 1.6 to calculate plasma concentrations from blood values. In the case of blood samples taken after death, the use of these models to assess the time of Cannabis use is not recommended.     

Additional standards for human blood and blood products; source plasma (human)--Food and Drug Administration. Final rule

The Food and Drug Administration [FDA] is amending the biologics regulations to make clear that an active plasmapheresis donor, who is to be immunized for the production of high-titer plasma, does not need to be reexamined before the first immunization injection if the same donor has previously received a physical examination for plasmapheresis in accordance with section 640.63(b)(1). This rule eliminates a burden on the individual plasmapheresis donor and the plasmapheresis center.